Leading Element Driving Change in the Intravenous Solutions Market in 2025: Rising Cancer Prevalence Driving The Intravenous Solutions Market Driver

What industry-specific factors are fueling the growth of the intravenous solutions market?
The rise in cancer instances globally is poised to stimulate the expansion of the intravenous solutions market. Cancer pertains to a collection of ailments typified by the undeterred proliferation of cells, both invading neighboring tissues and with the potential to metastasize to various body parts. Intravenous solutions play a crucial role in cancer treatment, both in the administration of chemotherapy drugs and ensuring hydration throughout treatment. For instance, in February 2024, the World Health Organization, a Swiss intergovernmental organization, projected over 35 million new cancer cases by 2050. This accounts for a 77% surge compared to the calculated 20 million cases in 2022. Therefore, the escalating occurrence of cancer fosters the intravenous solutions market's growth. Intravenous Solutions Market Driver: Escalation in Surgical Procedures Fuels Intravenous Solutions Market Growth

Get Your Intravenous Solutions Market Report Here:
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

What Is the projected market size and growth rate for the intravenous solutions market?
The size of the intravenous solutions market has shown significant expansion in the recent past. Predicted to rise from $14 billion in 2024 to $15.05 billion in 2025, the sector is expected to see a compound annual growth rate (CAGR) of 7.5%. The surge in the historic phase could be attributed to an increase in surgical procedures, a growing number of chronic diseases, the expansion of home healthcare, rigorous rules guaranteeing product safety, an enhanced emphasis on patient hydration, and global initiatives for emergency readiness.

In the forthcoming years, the intravenous solutions market is poised for robust expansion, with an anticipated worth of $20.51 billion in 2029, reflecting an 8.0% compound annual growth rate (CAGR). This propitious growth can be linked to several factors such as increasing population and aging, more surgical procedures, elevated occurrence of infectious diseases, telemedicine and remote patient observation, emphasis on preventive health measures, worldwide health safety investments, and patient-driven care attitudes. The significant trends seen within this period encompass growing demand for parenteral nutrition solutions, surge in acceptance of pre-blended IV solutions, burgeoning home infusion therapies, initiation of balanced electrolyte solutions, the advent of innovative drug additives and supplementary substances, and incorporation of smart IV systems for tracking.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp

What new trends are reshaping the intravenous solutions market and its opportunities?
Leading businesses in the intravenous solutions market are striving to develop innovative syringes, such as pre-filled and ready-to-use syringes, to establish a competitive advantage. Pre-filled and ready-to-use syringes come preloaded with medicine and are designed for immediate use without the need for manual filling or preparation. For example, in August 2023, US-based healthcare firm GENIXUS Corp. introduced the KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-use (RTA) syringes. The syringes are comprised of a clear, robust polymer material, mitigating the risks associated with glass syringes. These ready to administer syringes help in time efficiency and reducing medication errors. Rocuronium bromide injection is intended only for intravenous application. It features several critical attributes, such as RFID-enabled with KitCheck, a state-of-the-art kit and tray management tool, easy-to-read labeling, and a color-coded plunger rod for quick identification.

What major market segments define the scope and growth of the intravenous solutions market?
The intravenous solutions market covered in this report is segmented -

1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition
2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients
3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution
4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings

Subsegments:
1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions, Multivitamin Solutions
2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13465

Which region dominates the intravenous solutions market?
North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the intravenous solutions industry growth?
Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13465&type=smp

What Is Covered In The Intravenous Solutions Global Market Report?

•Market Size Forecast: Examine the intravenous solutions market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the intravenous solutions market for a structured understanding.
•Key Players Overview: Analyze major players in the intravenous solutions market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the intravenous solutions market.
•Segment Contributions: Evaluate how different segments drive overall growth in the intravenous solutions market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the intravenous solutions market.
•Industry Challenges: Identify potential risks and obstacles affecting the intravenous solutions market.
•Competitive Landscape: Review strategic developments in the intravenous solutions market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.